Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Oscar Bueno"'
Autor:
Felicia Alfano, Lucilio Cordero-Grande, Juan E. Ortuno, Karla Ferreres Garcia, Monica Garcia-Sevilla, Oscar Bueno Zamora, Mercedes Herrero Conde, Santiago Lizarraga, Andres Santos, Javier Pascau, Maria J. Ledesma-Carbayo
Publikováno v:
IEEE Access, Vol 10, Pp 122901-122911 (2022)
Breast cancer is the most common cancer in women worldwide. Screening programs and imaging improvements have increased the detection of clinically occult non-palpable lesions requiring preoperative localization. Wire guided localization (WGL) is the
Externí odkaz:
https://doaj.org/article/dab02da63518443bba681efb6ffb4ce1
Autor:
Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel García-Saenz, Maria del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez-Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution of
Externí odkaz:
https://doaj.org/article/6320cb09619d46bdb0b5fd843bc4c5e3
Autor:
Vladimir Rodríguez Rodríguez, Yurisán Tarrago León, Antonio De Arasoza Hernández, Victor Hugo Salvatierra Tabuada, Manuel García García, Oscar Bueno Bolaño
Publikováno v:
Revista Cubana de Cardiología y Cirugía Cardiovascular, Vol 24, Iss 2, Pp 203-211 (2018)
Actualmente la cirugía convencional constituye el patrón para implantar prótesis biológicas o mecánicas en el tratamiento de la estenosis aórtica sintomática. A pesar de esto, el remplazo valvular aórtico mínimamente invasivo muestra excelen
Externí odkaz:
https://doaj.org/article/e1cf416931f443a187a77ea55b109b4d
Autor:
Nora Yárnoz-Goñi, Ana Goñi-Navarro, Oscar Bueno-Sainz, Judith Alvarez-Borillo, Paula Mollà-Roig, Eva Gracia-Peligero
Publikováno v:
Revista de Psiquiatría Infanto-Juvenil. 39:42-45
Se presenta el caso de un adolescente derivado a la Unidad de Huntington para valoración psiquiátrica. Objetivos: Realizar diagnóstico diferencial entre la sintomatología de la enfermedad de Huntington juvenil (EHJ) y las conductas propias de un
Autor:
María Cebollero-Presmanes, Ana María Aragón Bodí, Javier Gayarre, Enrique Luis Álvarez, Ainhoa Arias, Sara López-Tarruella, Miguel Martin, I. Márquez-Rodas, Coralia Bueno, Yolanda Jerez, Paula Romero, Fernando Ángel Moreno, Ricardo González del Val, Maribel Palomero, J.A. García-Saenz, Antonio C. Picornell, Isabel Echavarria, Marta Muñoz, María del Monte-Millán, Oscar Bueno, Tatiana Massarrah, Inmaculada Ocaña, Rocío Ramos-Medina
Publikováno v:
JCO Precision Oncology. :1-16
PURPOSE Genetic heterogeneity between primary tumors and their metastatic lesions has been documented in several breast cancer studies. However, the selection of therapy for patients with metastatic breast cancer and the search for biomarkers for tar
Autor:
María del Monte-Millán, Patricia Rincon, Ivan Marquez-Rodas, Rebeca Bernat, José A. García-Sáenz, Isabel Echavarria, Paula Romero, Yolanda Jerez, Sara López-Tarruella, Rocío Ramos-Medina, Ricardo González del Val, Fernando Asensio, Eva González-Haba, Nerea Lobato, María Isabel Palomero, Miguel Martín, Fernando Salvador Moreno, Enrique Alvarez, Blanca Herrero, Tatiana Massarrah, Oscar Bueno, S. Lizarraga, Maria Cebollero
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution of each of
Autor:
Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel Garcia Saenz, Maria Del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez Del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Background: Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11249e33d57a11a01beba9dd4cddb109
https://doi.org/10.21203/rs.3.rs-57678/v1
https://doi.org/10.21203/rs.3.rs-57678/v1
Autor:
J A Pajares, M. Die-Trill, M. Martin, Sara López-Tarruella, Miriam Lobo, M Sanz, J.P. Justel, I. Márquez-Rodas, C González-Asanza, C Lopez, A Muñoz-Martin, C Flores-Sanchez, C Mata, Yolanda Jerez, S. Lizarraga, M Blanco, M I Peligros, S. Luque, Jesus Solera, Oscar Bueno
Publikováno v:
Europe PubMed Central
Objective: To analyse the evolution of a multidisciplinary heredofamilial cancer unit (HFCU) in a university hospital. Methods: This was a retrospective analysis of the activity of our HFCU in its first 5 years of existence. Results: Between July 201
Publikováno v:
International Journal of Integrated Care; Vol 17: Annual Conference Supplement 2017; A588
Introduction : Healthcare providers are currently struggling on how best to address the variety of care services demanded by an ageing population. Economic and workforce constraints characterise a risk adverse environment that hampers innovation in w
Autor:
S. Lizarraga, Ricardo González del Val, Miriam Lobo, Ivan Marquez-Rodas, Carmen Flores-Sánchez, Jesus Solera, Miguel Martin, Yolanda Jerez, Maria Cebollero, María Isabel Palomero, Soledad Luque, Oscar Bueno, Isabel Echavarria, Gabriela Torres, Sara López-Tarruella
Publikováno v:
Journal of genetic counseling. 27(4)
The identification of patients at risk for breast cancer by genetic testing has proven to reduce breast cancer mortality. In 2010, due to a lack of systematization in hereditary cancer assistance in our center, we implemented a multidisciplinary Here